(Q45788200)
Statements
1 reference
A prime-boost approach to HIV preventive vaccine using a recombinant canarypox virus expressing glycoprotein 160 (MN) followed by a recombinant glycoprotein 160 (MN/LAI). The AGIS Group, and l'Agence Nationale de Recherche sur le SIDA. (English)
1 reference
Pialoux G
1 reference
Excler JL
1 reference
Rivière Y
1 reference
Gonzalez-Canali G
1 reference
Feuillie V
1 reference
Coulaud P
1 reference
Gluckman JC
1 reference
Matthews TJ
1 reference
Meignier B
1 reference
Kieny MP
1 reference
1 March 1995
1 reference
11
1 reference
3
1 reference
373-381
1 reference
Identifiers
1 reference